22nd Centiry Group, Inc. (OTCMKTS:XXII) Down After Seven Days of Climbing
At the peak of a climbing streak, there always hangs the question- when will the correction happen. For 22nd Centiry Group, Inc. (OTCMKTS:XXII) the waiting is over. Last Friday came with profit-taking, bringing down the stock more than 6%. The dollar volumes of selling were above $555,000. This is the first retreat after seven days of buying and gains. 
The last time a correction happened for XXII, it lasted for several days, wiping out nearly a third of the price. Still, the slide went on slow enough, and this may be a positive trait in case selling continues. Despite the high levels, XXII still does not attract the interest of pumpers. 
The recent financial results coincided with the price climb, and may be a longer-term boost for the cigarette maker:
- $278,000 Cash
- $2.9 million Total assets
- $1.8 million Current liabilities
- $10 million Total liabilities
- Zero revenues
- $2.5 million Net loss
The next months will show how the ongoing efforts of XXII will be reflected on the stock markets.
The other nicotine seller, Vapor, Corp. (OTCMKTS:VPCO), also shows signs of struggling. After an encouraging peak, the ticker has moved sideways, hopping this and that side of the $1 level.
And despite the lucrative nature of tobacco and alcohol businesses, the last few days saw other similar stocks depressed. Just as Montalvo Spirits, Inc. (OTCBB:TQLA) was beginning to take off, a lag in promotional efforts caused a reversal and the ticker now goes as low as 70 cents after another small loss added on Friday.
The big news for XXII may be its engagement with the FDA, to approve the two types of cigarettes specially designed to lower the risk of smoking. The company also plans to ship out the Spectrum brand of cigarettes more actively. XXII lists as its advantage the modified tobacco which allows it to closely monitor nicotine content and offer a greater range of strengths.
While XXII may not work according to the laws of pharmaceutical companies, an expectation of a positive outcome could play out on the stock markets. In any case, XXII should also be taken with some doubts, and with awareness that corrections are very probable outcomes.
